This document is a term paper submitted by students of the Bachelor of Public Health program at La Grande International College in Nepal on the topic of the prevalence of non-communicable diseases. It provides background information on NCDs including risk factors. Global data shows NCDs account for 60% of deaths worldwide, with 80% occurring in low- and middle-income countries. In Nepal, NCDs account for 42% of all deaths currently and are projected to cause 66.3% of deaths by 2030. The term paper analyzes NCD prevalence in Nepal and compares communicable to non-communicable disease burdens. It also examines Nepal's NCD policies and strategies.
Epidemiology of Non Communicable Diseases (NCDs)Prabesh Ghimire
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
The Burden of Disease ( BOD) analysis describes in details the uses and effects of BOD. How to measure it. Special emphasis has been given in understanding HALY, DALY and QALY.
N.B: 1. Please download the ppt first, as the animations will act better then
2. There are few hidden slides in the presentation, which you may explore too.
NCD Prevention and Control as a Health System Strengthening InterventionAlbert Domingo
Lecture on NCD Prevention and Control as a Health System Strengthening Intervention delivered by Dr Albert Francis Domingo at the UP Manila College of Public Health on 19 January 2018.
Non-communicalbe diseases and its preventionShoaib Kashem
Non communicable disease account for a large and increasing burden of disease worldwide. It is currently estimated that non communicable disease accounts for approximately 60% of global deaths and 43% of global disease burden. This is projected to increase to 73% of deaths and 60% of disease burden by 2020.
Epidemiology of Non Communicable Diseases (NCDs)Prabesh Ghimire
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
The Burden of Disease ( BOD) analysis describes in details the uses and effects of BOD. How to measure it. Special emphasis has been given in understanding HALY, DALY and QALY.
N.B: 1. Please download the ppt first, as the animations will act better then
2. There are few hidden slides in the presentation, which you may explore too.
NCD Prevention and Control as a Health System Strengthening InterventionAlbert Domingo
Lecture on NCD Prevention and Control as a Health System Strengthening Intervention delivered by Dr Albert Francis Domingo at the UP Manila College of Public Health on 19 January 2018.
Non-communicalbe diseases and its preventionShoaib Kashem
Non communicable disease account for a large and increasing burden of disease worldwide. It is currently estimated that non communicable disease accounts for approximately 60% of global deaths and 43% of global disease burden. This is projected to increase to 73% of deaths and 60% of disease burden by 2020.
Epidemiology of Chronic Non- communicable diseases and ConditionsSheetal Singh
This presentation focuses on the most prevailing Non- Communicable diseases of the world. It includes the problem, causes, risk factors, prevention and worldwide statistics of each disease.
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. GBD 2017 incorporates major data additions and improvements, using a total of 68,781 data sources in the estimation process.
Screening for disease or Early detection of disease is detecting a disease at an earlier stage than would usually occur in standard clinical practice.
This denotes detecting disease at a pre-symptomatic stage, at which point the patient has no clinical complaint ( no symptoms or signs) and therefore no reason to seek medical care for the condition
Early detection of disease is beneficial and that intervention at an earlier stage of the disease process is more effective or easier to implement than a later intervention
Indicator is a variable which gives an indication of a given situation or a reflection of that situation.
Health Indicator is a variable, susceptible to direct measurement, that reflects the state of health of persons in a community.
Indicators help to measure the extent to which the objectives and targets of a programme are being attained.
NCDs, also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological, environmental and behaviours factors.
The main types of NCDs are cardiovascular diseases (like heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes
Epidemiology of Chronic Non- communicable diseases and ConditionsSheetal Singh
This presentation focuses on the most prevailing Non- Communicable diseases of the world. It includes the problem, causes, risk factors, prevention and worldwide statistics of each disease.
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. GBD 2017 incorporates major data additions and improvements, using a total of 68,781 data sources in the estimation process.
Screening for disease or Early detection of disease is detecting a disease at an earlier stage than would usually occur in standard clinical practice.
This denotes detecting disease at a pre-symptomatic stage, at which point the patient has no clinical complaint ( no symptoms or signs) and therefore no reason to seek medical care for the condition
Early detection of disease is beneficial and that intervention at an earlier stage of the disease process is more effective or easier to implement than a later intervention
Indicator is a variable which gives an indication of a given situation or a reflection of that situation.
Health Indicator is a variable, susceptible to direct measurement, that reflects the state of health of persons in a community.
Indicators help to measure the extent to which the objectives and targets of a programme are being attained.
NCDs, also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological, environmental and behaviours factors.
The main types of NCDs are cardiovascular diseases (like heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes
Abstract—Diabetes is a disease which is on continuous increase specialy in country like India. It involve is a multisystem so intend to affect quality of life of patients. So this study was conducted on 250 Diabetes Mellitus patients to observe their quality of life on various domains viz Physical, Mental, Social and environmental through WHOQOL-Bref questionnaire. It was found that 54.4% were unable to level their quality of life, they say neither good nor bad. But 23.2% were feeling bad and 22.4 % were feeling good about their quality of life. Whereas regarding patient's satisfaction about their health 39.2% were unable to level their quality of life and 35.6% were dissatisfied and 25.2 % were satisfied with their health. Significantly more cases were unable to understand about their quality of life than their satisfaction to their health. It was also found that Physical quality of life was affected most followed by environmental, psychological and social dimension of quality of life.
Comprehensive geriatric assessment (CGA) is a multidimensional, interdisciplinary diagnostic process to determine the medical, psychological and functional capabilities of a frail elderly person in order to develop a co-ordinated and integrated plan for treatment and long-term follow up
Policy Brief-Costly Disease: How to reduce out of pocket expenditure in Diabe...Anupam Singh
This policy brief assignment was submitted to instructor during my masters program in Development at AzimPremji University. This brief reflects upon the current status of diabetes in country with graphs and data points,and how it is addressed specially in the public health domain.
Disclaimer - this are the authors personal opinion and reflections build upon the data researched for academic submission purpose . it is in no way is exhaustive and claiming anything in particular in the health system. Feedback are welcome to construct and improve more on this academic assignment (Policy Brief).
Effectiveness of Gardening Therapy in Intergrating People with Mental illness into the Society
`
For more information, Please see websites below:
`
Organic Edible Schoolyards & Gardening with Children =
http://scribd.com/doc/239851214 ~
`
Double Food Production from your School Garden with Organic Tech =
http://scribd.com/doc/239851079 ~
`
Free School Gardening Art Posters =
http://scribd.com/doc/239851159 ~
`
Increase Food Production with Companion Planting in your School Garden =
http://scribd.com/doc/239851159 ~
`
Healthy Foods Dramatically Improves Student Academic Success =
http://scribd.com/doc/239851348 ~
`
City Chickens for your Organic School Garden =
http://scribd.com/doc/239850440 ~
`
Simple Square Foot Gardening for Schools - Teacher Guide =
http://scribd.com/doc/239851110 ~
Techniques of treatment on drug addicted people in sover life rehab centerNafiz Al Kalam
No nation on earth is untouched by the effects of drug abuse. The problem has reached such a
proportion that it has become a global threat. From the impoverished villages where drugs are
grown to the modern cities where they are ultimately sold, drugs follow a complex route that hits every country in the world; Bangladesh is no exception.
Organization Structure of Public Health System in Nepal.
Organization Profile (Structure, Functions, Roles, Responsibilities, ToR): http://bit.ly/HealthsystemsNepal
Organization Structure of Public Health System in Nepal | Health System Nepal | Current Health system of Nepal | Organization Structure of Nepalese Health System | Public Health System | Health Governance System in Nepal |Health Organization Profile | https://publichealthupdate.com |
More updates: https://publichealthupdate.com
Short orientation on reproductive health & Reproductive right (Nepali)Public Health Update
Short orientation on reproductive health & reproductive right.
(Note: Slide share can’t support Nepali fonts, if you are interested to read please download it and read clearly in computer after Installing Preeti Fonts)
Thank you.
ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL (Draft Seminar ...Public Health Update
This is Draft Seminar paper which will present in my class for partial fulfillment of my Syllabus of BPH 8th semester. ''ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL''
A Presentation Presented To orient about HIV, AIDS and STIs for Development of Knowledge, Attitude, and Practice for Prevention of HIV and STIs for College Students.
This is a simple and general presentation about the health research which is prepared to present within staffs of Naulo Ghumti Nepal especially for EIHS staffs, objective if this presentation is to orient staffs about research.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
1. ‘‘PREVALENCE OF NON-COMMUNICABLE DISEASE’’
A Term paper submitted to fulfill the partial requirement of BPH second semester [Basic
Epidemiology TPP 3.1]
SUBMITTED TO:
DEPARTMENT OF PUBLIC HEALTH,
LA GRANDEE INTERNATIONAL COLLEGE,
SIMALCHAUR-8, POKHARA
2011
SUBMITTED BY:
SAMJHANA GURUNG ‘A’
SAMJHANA GURUNG ‘B’
SABITA TIMILSINA
SARALA KUMAL &
SAGUN PAUDEL
2. 1. Acknowledgement
The students of Bachelor of Public Health 2nd semester of 1 st year like to express our humbly
thanks to all those who have supported and helped us in accomplishing this term paper in the
topic ‘‘PREVALENCE OF NON-COMMUNICABLE DISEASE’’.
We would like to convey our heartfelt thanks to all those who were directly or indirectly
concerned with this and to all our well wishers.
First of all we would like to thank our respected subject teacher Mr. Dilip Kumar Yadav for
giving us opportunity to prepare this term paper. We are fully indebted to our him for expert
guidance, regular supervision, untiring encouragement, inspiration and valuable suggestion and
full support during preparation of term paper.
This term paper is written in simple language, with every bit of necessary information related to
the topic so that studying independently also would not find any difficulties. We think that this
effort will help every individual to understand about the information of the related topic.
3. 2. TABLE OF CONTENT
1. Acknowledgement ...................................................................................................................................... 2
2. TABLE OF CONTENT .................................................................................................................................... 3
3. INTRODUCTION ........................................................................................................................................... 4
Risk factors:...................................................................................................................................................... 5
Major behavioral risk factors: .................................................................................................................... 5
Major biological risk factors: ...................................................................................................................... 5
Other risk factors......................................................................................................................................... 5
4. Objectives: ................................................................................................................................................... 6
General Objectives: ......................................................................................................................................... 6
Specific Objectives: ......................................................................................................................................... 6
5. Methodology: .............................................................................................................................................. 7
6. Finding and Discussion: .............................................................................................................................. 8
Global scenario: ............................................................................................................................................... 8
South-east Asian countries: ............................................................................................................................ 8
Nepal: ............................................................................................................................................................... 9
Some prevalent NCDS in Nepal: ...............................................................................................................10
Status of NCD’s in Nepal8..........................................................................................................................10
Facts and figures: ..........................................................................................................................................11
7. NCD Risk Factors: ......................................................................................................................................13
8. NCD’s Policy and Strategies of Nepal 9: ....................................................................................................14
9. Conclusion: ................................................................................................................................................14
10. Recommendation: ................................................................................................................................14
11. References:............................................................................................................................................15
4. 3. INTRODUCTION
Prevalence: all current old and new of a disease existing at a given point at a time over a period
of time.
Non-communicable disease: Impairment of bodily structure or functions that necessitates a
modification of the patient’s normal life and has persisted over extended life period of time.1
Charasteristics of NCD’S:2
NCD’s or chronic diseases are impairment or deviation from normal with these characteristics;
• Are permanent
• Leave residual disability
• Caused by non- reversible pathological alteration
• Require special training of the patient rehabilitation
• Requires long period of observations.
• Have long latent period between the exposure and causes.
• Disability and fatality rate is high.
• Mostly irreversible.
• Are slow in onset and development and long term impact.
• They require a long term systemic approach to treatment.
• Most chronic diseases are the result of multiple causes.
• NCDs have emerged as the major causes of morbidity and mortality worldwide.
1–
EURO sumposium, 1997
2- Commission of Chronic Illness, USA.
5. Risk factors:
The risk factors for many of these conditions are associated with environmental and genetic
factors.
Major behavioral risk factors:
Tobacco use (cigarette use and other forms of smoking)
Harmful alcohol consumption
Unhealthy diet(low fruit and vegetable consumption)
physical in activity
Stress factors etc.
Major biological risk factors:
Overweight and obesity
Raised blood pressure
Raised blood glucose
Abnormal blood lipids and its subset raised total cholesterol
Other risk factors
Failure to obtain preventive services
Environmental factors etc.
These risk factors have 80% contribution in the development of NCDs.
6. 4. Objectives:
General Objectives:
• To find out the prevalence of non-communicable disease in Nepal.
Specific Objectives:
• To identify the prevalence of top non-communicable diseases.
• To compare the prevalence of patients in different Developmental area of Nepal.
• To compare the prevalence of NCD’s in different years.
• To compare the prevalence of communicable diseases and non-communicable diseases.
• To analyze the risk groups and factors of NCD’S in Nepal.
• To find out the NCD Policy and Strategies of Government of Nepal.
8. 6. Finding and Discussion:
Global scenario:
• NCDs account for almost 60% of deaths and 47% of the global burden of disease.3
• Today, non-communicable diseases, mainly cardiovascular diseases, cancers, chronic
respiratory diseases and diabetes represent a leading threat to human health and
development. These four diseases are the world’s biggest killers, causing an estimated 35
million deaths each year - 60% of all deaths globally - with 80%in low- and middle-
income countries.4
• 75% of the total deaths due to NCDs occur in developing countries.5
• out of 58 million deaths from all, NCDs account for 35 million deaths.6
• Estimated that in 2020, the no. of deaths caused by NCD’s in developing countries will
equal the death caused by communicable diseases.
• By 2020,chronic heart disease are expected to account for7 of 10 deaths in world.7
South-east Asian countries:
• World Health Organization (WHO) estimates about 54% of deaths and 44% of morbidity
is attributed to NCDs in this region.
• In Nepal, NCDs accounts for 42% of all deaths and is projected to cause 66.3% of
all deaths by 2030.
3- World Health Report 2004
4-Menzies Research Institute Tasmania, Non-communicable Diseases. [Cited 2010 20 August]; Available from:
http://www.menzies.utas.edu.au5- World Health Report 2004
6- World Health Report 2005
7-
Habib SH, Soma S. Burden of non communicable disease: Global overview. Health Economics Unit, Diabetic
Association of Bangladesh, 122 Kazi Nazrul Islam Avenue, Dhaka 1000, Bangladesh (available online April 1,
2010)
9. Nepal:
Nepal, one of the poorest countries in the world - at 136th position of human
development index has grossly limited treatment options for NCDs and their end organ
effects.
Nepal is one of the developing countries of the world. It is facing double burden of
diseases with an added burden of NCDs. Many researches on NCDs were conducted in
Nepal but magnitude of NCDS is still unknown.
Death and DALY rates of the NCDs in Nepal (by, 2002)
Death Rate (age DALY Rate (age standardized,
standardized, per per 100,000 population)
100,000 population)
CVD 310 2,285
Cancers 120 1,186
Respiratory diseases 94.5 1,102
Diabetes 30.8 322
All NCDs 795.9 13,467
Road Traffic Injuries 19.7 526
Source: Nepal public health association.
10. Some prevalent NCDS in Nepal:
• Cardiovascular diseases such as; Ischemic heart disease(IHD),Hypertension, Rheumatic
heart disease (RHD’s)
• Diabetes
• Mental disorders
• cancers
• Chronic respiratory disease
• Obesity
• Blindness
• Hearing impairment
• Oral health and other chronic diseases
• Accidents and injuries etc.
Status of NCD’s in Nepal8
According to the WHO Global Report " Preventing Chronic Disease: A Vital Investment, 2005’’
42% of total deaths are caused by NCD, of which;
CVD holds the top most position with 21% of all deaths,
Followed by cancer (7%),
Chronic respiratory disease (5%),
And Diabetes (2%).
Road traffic injuries account for 9% of all deaths,
Other chronic disease and rest of the chronic diseases being 7%.
• This composition is similar to Regional scenario. WHO global info base provides a
projection for the year 2030, which suggest a 66.2% increase in deaths caused by CVD
and 71.4% by Cancer.
8-Non-communicable Diseases: Emerging Trends and Socio-economic impact, Dr. Mahesh Maskey MBBS,
MPH, DSc. ,Executive Chair, Nepal Public Health Foundation,17 Sept, 2010.
11. Facts and figures:
According to Annual report of MOHP in Nepal (2006), In government hospital 81.5% outpatient
and 88% of in-patient attendance is due to morbidity related to NCD’s.
Annual report 2065-66:
Communicable and Non-Communicable Cases among the total OPD Cases by National and
Regions, FY 2065/66 (2008/2009)
Level Communicable Non communicable
Eastern 889,918 3,556,605
Central 1,037,141 4,240,881
Western 718,054 3,515,735
Mid Western 697,014 388,314
Far Western 386,611 1,517,650
National 3,728,738 15,219,185
Source: HMIS/MD, DoHS
From data:
This shows the communicable and non-communicable cases at the National level. The total OPD
new visits more than 80.0 % of the total patients have visited for non communicable diseases
where as patients visiting for communicable diseases represent only less than 20.0 %.
12. Annual report 2066-67:
Communicable and Non-Communicable Cases among the total OPD Cases by National and
Regions, FY 2066/67 (2009/2010)
Level Communicable Non communicable
Eastern 968,735 3,917,213
Central 1,015,132 4,660,491
Western 625,523 4,059,816
Mid Western 760,996 2,648,755
Far Western 431,843 1,805,614
National 3,802,229 17,091,889
Source: HMIS/MD, DoHS
From data:
This shows the communicable and non-communicable cases at the National level. The total OPD
new visits more than 81 % of the total patients have visited for non communicable diseases
where as patients visiting for communicable diseases represent only less than 19.0 %.
Comparative study:
• In 2065-66, 80% of OPD patients are suffered from NCD’S and in 2066-67, there is
increase in the % of patients by 1%.
• Similarly the no. of patient who suffered from NCD’S is increased rapidly in compare
with communicable diseases.
• In every developmental region there is high number of OPD patient suffered from
NCD’S.
13. Total number of Inpatient morbidity by communicable and non-communicable diseases :
Source: HMIS/MD, DoHS FY 2066-67
Communicable Non- Communicable Non-
diseases Communicable diseases Communicable
diseases diseases
Number of in (42,683) Source: HMIS/MD, 6,039) (264,327)
patient 14.28% DoHS 12.00% 88.00%
Death Rate 0.57% Source: HMIS/MD, 1.20% 1.00%
among DoHS
Inpatient
Source: HMIS/MD, DoHS
Description:
• In FY 2065-66: 86 % of the in patients were admitted for non-communicable diseases
where as only 14 % of the discharged patients were admitted for the communicable
diseases.
• Similarly in FY 2067-68: 88 % of the in patients were admitted for non-communicable
diseases where as only 12 % of the discharged patients were admitted for the
communicable diseases.
7. NCD Risk Factors:
• Several surveys have been conducted to measure the NCD risk factors in Nepal. All these
survey show high prevalence of risk factors.
• According the national survey of 2008, among the four major risk factors current tobacco
use (both smoke and smokeless) was 37%. Regarding alcohol consumption current
consumers were 28.5%.
• Among the daily drinkers, One in three men and one in ten women were drinking harmful
amount of alcohol (>60 gms of alcohol).
• More than five serving of fruits and vegetables were recommended for healthy living.
However, the survey shows that 60.5% women are currently consuming less than 5
serving of fruit and vegetable daily in Nepal.
14. • And almost 95% of surveyed population was found to be engaged in either moderate or
high level of physical activity.
Source: Nepal public health foundation.
8. NCD’s Policy and Strategies of Nepal 9:
• Regional Framework of WHO SEARO provides a comprehensive and stepwise approach
to prepare the national policy, strategy and build capacity for prevention and control of
NCD.
• In Nepal a draft of "National policy, strategy and plan of action for prevention and
control of non-communicable disease" has been prepared by MOHP.
• This document was prepared in the year 2009 but has not been endorsed by
the government as yet. Though there are enough room for improvisation,
nonetheless, this document correctly advocates for a comprehensive and integrated
approach in reducing the burden of disease in Nepal.
• This approach is most pointedly expressed in following paragraph:
• "Primary prevention of NCD is the most cost effective method to tackle the growing
epidemics of NCDs. Secondary and tertiary prevention incurs huge cost in one hand and
the facilities to carry out secondary and tertiary prevention is unlikely to be available
everywhere in Nepal in near future. The only resort that Nepal can afford is to go for
primary prevention and is feasible if integrated approach is adopted’’
9- MOHP, (2009)Nepal National Policy, Strategy and Plan of Action " for Prevention and Control of Non-
Communicable Diseases" (draft), Government of Nepal. Kathmandu.
9. Conclusion:
In conclusion, the magnitude of non communicable disease is substantial in Nepal and is
regarded as a public health problem. The governmental, non-governmental and
community based organizations are still fighting to tackle the burden of infectious
diseases. Unless urgent and specific focus on preventing, treating and control of NCDs
are targeted, the burden of the NCDs will be unbearable to the poor nation like Nepal.
10. Recommendation:
• Prevention of NCDs requires an integrated action across a range of sectors at local,
regional and national levels. Each individual sector can perform a specific role to
contribute from their level. Health care and public health must play a fundamental role in
15. providing care and support for the patients but also in applying the unique public health
models to prevent the associated risk of NCDs.
• Infrastructure of hospital for NCDs and Diagnostic and treatment facilities.
• Physicians and health workers should be routinely trained and re-trained on the
prevention and control measures of NCDs.
• There should be provision of supply of low cost drugs to the diabetic patients by the
Government of Nepal.
• Preventive part of non communicable disease should be emphasized and given high
priority in treating NCDs.
• Health promotional activities using media should be of priority.
• Most of the health institutions do not have separate unit for NCDs where a patient could
receive a quality treatment. There should have separate unit for NCDs patients at least at
the tertiary level health facilities.
11. References:
• EURO sumposium, 1997
• Commission of Chronic Illness, USA
• World Health Report 2004
• Menzies Research Institute Tasmania. Non-communicable Diseases. [cited 2010 20
August]
• World Health Report 2004
• World Health Report 2005
• Habib SH, Soma S. Burden of non communicable disease: Global overview. Health
Economics Unit, Diabetic Association of Bangaladesh, 122 Kazi Nazrul Islam Avenue,
Dhaka 1000, Bangaladesh (available online April 1, 2010)
THANKYOU